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The 3xTg-AD mouse develops a progressive Alzheimer’s disease- (AD-) like brain pathology that causes cognitive- and
neuropsychiatric-like symptoms of dementia. Since its neuroimmunoendocrine axis is likewise impaired, this mouse is also useful
for modelling complex age-related neurodegeneration. This study analyzed behavioral, physiological, neurochemical, pathological
and immunoendocrine alterations in male and female 3xTg-AD mice and assayed the eﬀects of a short therapy of forced physical
exercise at the moderate pathology stage of 6 months of age. Gender eﬀects were observed in most AD-related pathology and
dysfunctions. Five weeks of treadmill training produced beneficial eﬀects, such as the reduction of brain oxidative stress and
GABA-A receptor dysfunction in males and improvement of sensorimotor function in females. In both sexes, exercise decreased
the brain amyloid β 42/40 ratio levels. The results highlight the importance of analyzing experimental therapies in both mouse
model genders in order to improve our understanding of the disease and develop more appropriate therapies.
1. Introduction
Alzheimer’s disease (AD) is the leading cause of dementia in
people over 65, and it aﬀects more than 20 million people
worldwide [1]. No cure has yet been found, and current
pharmacological therapy only temporarily ameliorates the
symptoms [2]. Recent research has focused on preventive
strategies derived from a healthier lifestyle, which may
decrease the incidence of AD in the population [3]. One
such strategy is physical exercise. Regular physical exercise
enhances brain functionality and protects against neurode-
generation through multiple pathways. Regular exercise can
attenuate oxidative damage in brain by reducing the ROS
production and increasing the antioxidant systems [4]. These
eﬀects indicate that exercise could be a preventive tool
against neurodegeneration-associated oxidative challenge.
Also in brain, exercise can upregulate the expression of
growth factors, such as BDNF, VEGF, FGF-2, NGF, and IGF-
1 that regulate synaptic plasticity, learning, neurogenesis,
and angiogenesis indicating an involvement of exercise in
these cerebral processes [5]. On the other hand, exercise is
suggested to reduce Aβ accumulation in cortical areas of AD
transgenic mouse by increasing proteolytic degradation by
proteasome [6]. The exact molecular mechanisms underly-
ing these favorable eﬀects of exercise in brain are not well
known, but the MAPK, PI3K, and PI/Akt signaling pathways
and the transcription factor CREB have been involved at the
molecular level [5]. Exercise also can change the function
of glutamatergic systems, increasing both NR2A and NR2B
subtypes of the NMDA receptor in the hippocampus [7],
which are crucial in learning and memory processes.
The health and psychological benefits elicited by regular
physical activity in older adults contribute to healthy aging
[8, 9]. Therefore, physical exercise is a potential intervention
to preserve or ameliorate cognitive function and behavior in
AD. Indeed, exercise is associated with a reduced incidence
of AD in the at-risk population [10]. Moreover, improved
cognition through exercise has been described in older adults
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at risk for AD [11]. Physical exercise programs ameliorate
mood [12] and symptoms of depression [13, 14] in AD
patients. However, the timing and duration of the exercise
required to be eﬀective against disease symptoms, as well as
the underlying mechanisms, are not known. Anticipated low
adherence of AD patients to exercise regimes could be an
obstacle for clinical studies, although this can be overcome,
at least in part, by experimental studies. Transgenic mouse
models of AD are useful and reliable experimental models
for testing anti-AD therapies. Several studies have reported
some pathology amelioration in AD transgenic mice as a
result of physical exercise, either assaying voluntary exercise
with a freely available running wheel [15, 16] or forced
exercise with a treadmill [16–19]. However, more studies
are needed to understand the eﬀects and consequences of
physical exercise intervention on the pathological cascade of
AD neurodegeneration. Gender diﬀerences have not been
extensively explored in the literature yet. In parallel, more
studies are also needed to find out diﬀerential gender
responses both in normal and mutant animals.
This study used the mandatory treadmill exercise
paradigm in AD triple transgenic mice (3xTg-AD) [20].
These mice develop age-dependent and progressive neu-
ropathology that includes plaque and tangle pathology [21].
Their associated behavioral disturbances include cognitive
and noncognitive symptoms (i.e., Behavioral and psycho-
logical symptoms of dementia, BPSD) and other neuronal
symptoms that mimic AD dementia [22]. In addition, these
mice present a gender-related progression of AD changes [23,
24]. Therefore, 3xTg-AD is a valuable model for preclinical
intervention studies. As few as 2–5 weeks of moderate
intensity, treadmill running has been demonstrated to
promote nerve cell regeneration and improve learning and
memory in rodents [25–27]. However, some previous studies
of treadmill eﬀects in AD transgenic mice were extended
to 12 weeks [17, 19] or 16 weeks [18, 28]. This study
evaluates the eﬀects of just 5 weeks of treadmill exercise on
the brain and peripheral organ function of 3xTg-AD mice at
several levels of study, namely the cellular (oxidative stress),
neurochemical (GABA function), physiological (body weight
curve, glucose homeostasis), immunoendocrine (involution
of thymus, plasma levels of glucocorticoids), behavioral
(BPSD-like and cognition impairments), and neuropatho-
logical (presence of amyloid and tau pathologies). The eﬀects
of exercise on physical functions were evaluated by means
of sensorimotor tasks, including muscular strength and
coordination. Emphasis was placed on the diﬀerential AD-
like pathology severity present in male and female 3xTg-AD,
which underlines the importance of translating the findings
of therapeutic studies in this animal model to AD.
2. Materials and Methods
2.1. Animals. 3xTg-AD mice harboring PS1/M146V, APP-
Swe, and tauP301L transgenes were genetically engineered at
the University of California Irvine, as previously described
[20]. Six-month-old male and female 3xTg-AD mice
from the Spanish colony of homozygous 3xTg-AD mice
established in the Medical Psychology Unit, Autonomous
University of Barcelona [22, 29] were used in this study.
Genotypes were confirmed by PCR analysis of DNA obtained
from tail biopsies. Three to five littermates of the same
genotype and sex were maintained (Makrolon, 35 × 35 ×
25 cm) under standard laboratory conditions (food and
water ad lib, 22 + 2◦C, 12 h light: dark starting at 08:00).
Thirty-six 3xTg-AD mice were subjected to five weeks of
exercise on a treadmill (see below), after which their behavior
was assessed on a series of tests used to screen for behavioral
abnormalities in mutant mice [22, 30]: physical condition
by body weight and sensorimotor tasks (SMT); BPSD-like
behaviors, including the corner test (CT), open-field (OF),
dark-light box (DLB), and T-maze (TM); several tasks to
assess spatial learning and memory in the Morris water maze
(MWM). Behavior was evaluated using both direct obser-
vation and a video-computerized tracking system (SMART,
Panlab S.A.) by two independent observers who were
unaware of the animal’s genotype. Eighteen nontransgenic
(non-Tg) mice with the same genetic background were used
as a reference group. Experiments were performed under
dim white-light conditions (16–20 lux) from 10:00 to 13:00
and in accordance with Spanish legislation on “Protection
of Animals Used for Experimental and Other Scientific
Purposes” and the European Communities Council Directive
(86/609/EEC) on this subject.
2.2. Administration of Exercise on the Treadmill. The ani-
mals were divided into two sets according to their gender
(males/females) and thereafter randomly assigned to one of
two treatment groups (exercise, EXE; no exercise or seden-
tary, SED). Treatments were administered from Monday to
Friday, between 9:00 and 19:00 in a soundproof room under
dim light. The experimental design was counterbalanced by
gender each day (starting with males in the morning and
females in the afternoon, and vice-versa on the next day)
and per treatment. The sedentary group (without exercise)
was placed on the treadmill running apparatus (Scientific
Instruments L18706) for the same amount of time as the
animals doing exercise. Animals were constantly monitored,
and the training of exercise group was slowly increased over
time and by speed, that is, from minimum (15 min/day,
5 cm/s) to moderate exercise (30 min/day, 7 cm/s). The
treadmill was carefully cleaned between animals, including
a 30-min rest period without animals when starting the set
of animals of the opposite gender.
2.3. Physical and Behavioral Profile of 3xTg-AD. Two days
after the end of the administration of exercise, several phys-
ical, physiological, and neuroimmunoendocrine parameters
were studied and compared to those of non-Tg mice.
2.3.1. Physical Conditions: Weight and Sensorimotor Func-
tions. The body weight of animals was monitored every
day before and after the treatments. The weight of intra-
abdominal white adipose tissue (WAT) was measured. The
contribution of WAT to total body weight was calculated as
the percentage of the weight of WAT versus the total body
weight.
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Reflexes (visual reflex and posterior legs extension reflex
tests) were measured three times by holding the animal
by his tail and slowly lowering to a black surface. The
motor coordination and equilibrium were assessed by the
distance covered and the latency to fall oﬀ a horizontal
wooden rod (1.3 cm wide) on two consecutive 20 s trials,
respectively. In order to increase the diﬃculty of the task,
the test was repeated on a metal wire rod (1 cm diameter).
Prehensility and motor coordination were measured as the
distance covered on the wire hang test, which consisted
in allowing the animal to cling from the middle of a
horizontal wire (diameter: 2 mm, length: 40 cm, divided into
eight 5 cm segments) with its forepaws for two trials of
5 s and a third 60 s trial. Muscle strength was measured
as the time until falling oﬀ the wire in the 60 s trial.
All the apparatus were suspended 40 cm above a padded
table.
2.3.2. Corner Test. Neophobia to a new home-cage was
assessed by introducing the animal into the center of the
standard cage (Makrolon, 35×35×25 cm) and counting the
number of visited corners and rearings during a period of
30 s. Latency of the first rearing was also recorded.
2.3.3. Open-Field Test. Mice were placed in the centre of the
apparatus (home-made, wooden, white, 55×55×25 cm high)
and observed for 5 min. Horizontal (crossings of 5 × 5 cm
squares) and vertical (rearings) locomotor activities were
recorded for each minute of the test. We also recorded the
latency of the sequence of the following behavioral events:
initial freezing (latency of initial movement), thigmotaxis
or discrimination of unprotected/protected areas in the test
(latency of leaving the central 5 × 5 cm square and that
of entering in the peripheral ring 5 cm to the walls), and
self-grooming behavior (latency, number, and duration of
groomings). Defecation was also measured.
2.3.4. Dark-Light Box Test. Anxiety-like behavior was also
measured in the dark-light box (Panlab, S.L., Barcelona,
Spain). The apparatus consisted of two compartments
(black, 27 × 18 × 27 cm; white, 27 × 27 × 27 cm; lit with
a 20 W white bulb) connected by an opening (7 × 7 cm).
The mice were introduced into the black compartment and
observed for 5 min. Latency to enter (all four paws) the lit
compartment, the time spent in the lit compartment, and
the horizontal (crossings of 3× 3 cm) and vertical (rearings)
activities developed once they were recorded.
2.3.5. Morris Water Maze Tests. Animals were tested for
spatial learning and memory in the MWM [31] consisting
of four trials of place learning for spatial reference memory
followed by one probe trial and one day of cue learning.
In the place-learning task, mice were trained to locate a
platform (7 cm diameter, 1.5 cm below the water surface)
in a circular pool (Intex Recreation Corp. CA, USA; 91 cm
diameter, 40 cm height, 25◦C opaque water) located in a test
room with distal visual cues. The acquisition task consisted
of four trial sessions per day, with trials spaced 15 min apart.
In each trial, the mouse was gently released (facing the wall)
from one randomly selected starting point (N, S, E, or W)
and allowed to swim until escaped onto the platform (always
in the middle of the SE quadrant). Mice that failed to find
the platform within 60 s were placed on it for 20 s, the same
period as was allowed for the successful animals. In session 4,
one and a half hour after the fourth trial of place learning,
the platform was removed from the maze and the mice
performed a probe trial test of 60 s. On the following day, the
animals were tested for the cue learning of a visual platform
consisting of four trials in one single day. The platform was
elevated 1 cm above the water level with its new position
(NW) indicated by a visible striped flag (5 × 8 cm), and the
distal cues were removed.
During each trial of the learning tasks the escape latency,
the distance traveled, and the mean speed were measured by
means of the computerized tracking system (SMART, Panlab
S.A., Barcelona, Spain). The number of annulus crossings
during the probe trial was also measured.
2.3.6. T-Maze Test. The spontaneous exploratory behavior
of mice was tested in a T-shaped maze (with arms 25 cm
in length). Animals were placed inside the “vertical” arm of
the maze with its head facing the end wall. The performance
was evaluated by determining with a chronometer the time
elapsed until the animal crossed (four paws criteria) the
intersection of the three arms [32].
2.4. Intraperitoneal Glucose Tolerance Test. Three days after
the end of the behavioral assessment, mice were assayed for
glucose tolerance with the intraperitoneal glucose tolerance
test (IPGTT) [33]. Baseline glucose was measured from tail
vein blood in mice fasted overnight. Mice were then loaded
by intraperitoneal injection with a solution of 2 g glucose/kg
body weight. Blood samples were subsequently collected
15, 30, and 60 min after glucose administration using a
standardized glucometer. Results are expressed as mg/dL.
2.5. Glucocorticoid Analysis. Mice were sacrificed by decap-
itation. Samples of about 1 mL of whole trunk blood were
collected at the time of sacrifice into heparinized tubes
and centrifuged immediately at 10,000 ×g for 2 min. The
plasma obtained was stored at –20◦C. Corticosterone content
(ng/mL) was analyzed using a commercial kit (Corticos-
terone EIA Immunodiagnostic Systems Ltd, Boldon, UK)
and ELISA EMS Reader MF V.2.9-0.
2.6. Target Samples. Brain was dissected to obtain hippocam-
pus, cerebral cortex, and cerebellum. Tissue samples were
stored at−80◦C for further biochemical analysis (see below).
The size (weight in mg) and relative size (% versus body
weight) of the thymus were recorded as an indirect measure
of the putative impairment (involution) of the peripheral
immunological system [24].
2.7. Immunohistochemistry. The hemibrain of four animals
per group was fixed by immersion in 4% paraformaldehyde
for 48 h. Paraﬃn-embedded brain sections were cut at
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8 mm. Sections were autoclaved in citrate buﬀer pH 6 for
10 min to expose the epitopes. The endogenous peroxidase
activity was quenched for 15 min in 1% H2O2. Sections were
immunostained with antiamyloid β (Aβ), clone 4G8 (Cov-
ance, Emeryvlle, CA, USA) or anti-paired helical filament tau
(PHF-tau), clone AT180 (Thermo Scientific, Rockford, IL) at
dilutions of 1 : 50 and 1 : 100, respectively, both overnight at
4◦C. After subsequent washes to remove primary antibody
excess, sections were incubated with the appropriate biotin-
conjugate secondary antibody for 1 h at room temperature.
Sections were developed with diaminobenzidine (DAB)
substrate using the avidin-biotin horseradish peroxidase
system (Vector Laboratories, Inc.).
2.8. Amyloid β ELISA. Cerebral cortex was homogenized
in a buﬀer containing 50 mM Tris, 400 mM NaCl, 2 mM
EDTA, 0.1% triton X-100, 2% bovine serumalbumin, and
a cocktail of protease inhibitors (Complete, Calbiochem).
Samples were centrifuged at 12,000 ×g for 7 min at 4◦C,
and supernatants were collected and used to detect Aβ by
ELISA. Both Aβ40 and Aβ42 soluble levels were measured
by sandwich ELISA [34]. Antibody clone 6E10 against
Aβ1–17 (Chemicon, Temecula, CA, USA) was used as a
capture antibody and rabbit polyclonal anti-Aβ40 and anti-
Aβ42 (Chemicon) as detection antibodies. After incubation
for 3 h, wells were washed, and a horseradish peroxidase-
conjugated antirabbit (GE Healthcare, UK) was added. Wells
were washed with phosphate-buﬀered saline (PBS), and
Quantablue reagent (Pierce, Rockford, IL, USA) was added.
Samples were then measured at 320 nm using a plate reader
(iEMS Reader MF; Labsystems, Vantaa, Finland).
2.9. [3H] Flunitrazepam Binding Assay. Synaptic membrane
preparations were obtained from mice cerebral cortices
that had been stored frozen at −80◦C. Brain samples were
thawed and homogenized in 50 volumes (w/v) of Tris-HCl
buﬀer (50 mM, pH 7.4) and then centrifuged at 20,000
×g, at 4◦C, 20 min. The pellet was resuspended in 1.5 mL
of the same buﬀer and again centrifuged at 20,000 ×g,
at 4◦C, 20 min. This procedure was repeated five times.
The last suspension was frozen at −80◦C for at least one
day. For the binding assays, the samples were thawed and
centrifuged, and the membranes were then resuspended in
1 mL of 50 mM Tris-HCl buﬀer/NaCl 200 mM. Proteins were
measured in 200 μL following the Bradford method. Mem-
branes were then incubated with 1 nM [3H] flunitrazepam
for 30 min at 25◦C. Binding obtained in the presence of
20 μM diazepam was considered to be nonspecific. After
incubation the suspensions were rapidly filtered in a Brandel
(Gaithersburg, MD, USA) and washed through Whatman
GF/B filters (435 μm). The amount of bound radioactivity
was determined following the addition of 2 mL of OptiPhase
“Hisafe” scintillation cocktail in a Wallac 1414 Winspectral
liquid scintillation counter (Perkin Elmer, Waltham, MA).
Radioligand binding data were subjected to Scatchard analy-
sis in order to obtain the neurochemical variables for binding
site density (Bmax, in pmol/mg protein) and binding aﬃnity
(Kd, in nM).
2.10. Lipid Peroxidation, Glutathione Peroxidase, and Super-
oxide Dismutase Assays. For lipid peroxidation and enzy-
matic assays, 100 mg of cerebral cortex tissue was sonicated
for 30 s in 1 mL of ice-cold 50 mM potassium phosphate
buﬀer containing 1 mM EDTA pH 7.4 and before being
centrifuged at 12,000 ×g for 30 min at 4◦C. The super-
natants were collected and stored at −80◦C until assay.
Enzymatic activities and lipid peroxidation were deter-
mined as described previously [35]. Peroxidation of lipids
was measured by determining malondialdehyde and 4-
hydroxyalkenal (MDA + 4-HAD) using a Lipid Peroxidation
Assay Kit from Calbiochem (EMD Biosciences Inc., Darm-
stadt, Germany). Glutathione peroxidase (GPx) activity
was determined by measuring spectrophotometrically the
rate of NADPH oxidation in the presence of hydrogen
peroxide. Superoxide dismutase (SOD) activity was mea-
sured using the SOD assay kit Ransod (Randox Labora-
tories Ltd, Crumlin, UK), based on the xanthinexanthine
oxidase system. After total SOD (Cu/Zn SOD and Mn
SOD) was determined, samples were again analyzed in
the presence of 500 μM KCN to inhibit CuZn SOD
and to obtain Mn SOD activity. SODCuZn activity was
obtained by subtracting Mn SOD activity. Proteins were
measured in 10 μL of supernatants following the Bradford
method.
2.11. Reduced Glutathione and Oxidized Glutathione Assays.
For reduced glutathione (GSH) and oxidized glutathione
disulphide (GSSG) assays, 200 mg of cerebral cortical tissue
was sonicated in 1 mL of 3.3% sulphosalicylic acid. Acid
homogenates were centrifuged at 12,000 ×g for 30 min at
4◦C, and supernatant fractions were collected and stored
at −80◦C until assay. The levels of GSH and GSSG
were determined using an enzymatic assay [36] that is
essentially a modification of Tietze’s recycling method.
Samples for GSSG determination were previously incubated
at room temperature with 2 μL of 2-vinyl pyridine per
100 μL sample in order to conjugate any GSH present in
the sample, such that only GSSG was recycled to GSH.
Both GSH and GSSG samples were then neutralized by
the addition of 6 μL of triethanolamine. For total glu-
tathione determination, 50 μL of each sample was mixed
with 100 μL of 100 mM sodium phosphate/1 mM EDTA
buﬀer containing 1 mM dithiobisnitrobenzoate, 20 U/mL
glutathione reductase, and 1 mM β-nicotinamide adenine
dinucleotide phosphate (NADPH). The kinetics of the
formation of 5-thio-2-nitrobenzoic acid was immediately
recorded at 30◦C and 405 nm, every 15 s over a 5-min
period.
2.12. Statistics. Statistical analyses were performed using
SPSS 12.0 software. Two-way ANOVA was performed using
gender and treatment as the independent variables for
detecting the respective eﬀects. Post hoc comparisons were
carried out using a post hoc Duncan’s test, unless otherwise
stated. Temporal courses were analyzed using repeated-
measures ANOVA (RMA), and when comparing two time
points, paired t-test was used.
International Journal of Alzheimer’s Disease 5
Table 1
(a) The treadmill exercise exerted beneficial eﬀects on the sensorimotor function which were more relevant in females
M non-Tg M TgSED M TgEXE F non-Tg F TgSED F TgEXE
(n = 8) (n = 10) (n = 10) (n = 8) (n = 8) (n = 8)
Body weight
Weight curve
Start of week 1 (g) 34.4± 0.7 36.0± 0.8 39.2± 1.8 24.7± 1.2 32.3± 1.2 32.0± 1.4
End of week 5 (g) 34.4± 0.4 37.0± 0.7 38.4± 1.6∗ 23.8± 0.3∗ 28.8± 1.0# 29.7± 1.2#
WAT (% versus body weight) See Figure 1
Sensorimotor function
Reflex tests
Incidence of both reflexes 8/8 10/10 10/10 8/8 8/8 8/8
Wooden rod test
Equilibrium (mean latency
to fall, s)
8.3± 2.2 17.5± 1.4 19.2± 0.5 14.5± 2.1 20.0± 0.0 20.0± 0.0
Coordination (mean
distance, cm)
2.5 + 1.5 3.2± 2.0 5.7± 2.5 1.4± 0.7# 5.3± 4.3# 39.7± 8.4#
Wire rod test
Equilibrium (mean latency
to fall, s)
3.0± 0.5 9.4± 1.9 9.8± 1.7 3.5± 0.8# 15.4± 1.6# 16.7± 1.6#
Coordination (mean
distance, cm)
0± 0 0± 0 5.3± 4.0 0± 0# 0.9± 0.9# 19.7± 6.6#
Wire hang test (2 trials 5 s)
Strength (mean latency to
fall, s)
0.9± 0.1 4.1± 0.4∗ 4.2± 0.3∗ 0.9± 0.3 4.5± 0.2∗ 5.0± 0.0∗
Coordination (mean
distance, cm)
0± 0 0.5± 0.3 0.6± 0.4 0± 0 0.3± 0.3 1.1± 0.3
Elements of support (n) 1.1± 0 1.5± 0.4 1.2± 0.3 0.8± 0.1 1.25± 0.4 2.3± 0.4
Wire hang test (1 trial 60 s)
Strength (mean latency to
fall, s)
4.0± 2.6 34.1± 7.6∗ 33.4± 6.4∗ 1.0± 0.1 55.7± 4.2#,∗ 55.0± 5.0#,∗
Coordination (mean
distance, cm)
0.3± 0.3 2.4± 0.6∗ 3.1± 0.5∗ 0± 0 5.0± 1.7∗ 6.7± 1.1#,∗
Elements of support (n) 1.7± 0.3 2.4± 0.3 2.4± 0.3 1.1± 0 2.8± 0.2 3.0± 0.0#,∗
Note: non-Tg, nontransgenic mice; TgSED, 3xTgAD mice not exercised; TgEXE, 3xTg-AD mice submitted to a daily treadmill running for five weeks. The
body weight, fat composition, and sensorimotor function of 3xTg-AD mice diﬀered from that of non-Tg mice. The treadmill exercise exerted beneficial
eﬀects on the sensorimotor function which were more relevant in females. Results are the mean ± SEM, n = 8–10 as indicated. Statistics: ∗P < .05
compared to non-Tg; #P < .01 compared to TgSED.
(b) BPSD-like behaviors are characteristic of 3xTg-AD mice at early stages of the disease and show an important gender component
M non-Tg M TgSED M TgEXE F non-Tg F TgSED F TgEXE
(n = 8) (n = 10) (n = 10) (n = 8) (n = 8) (n = 8)
Corner test
Vertical activity (latency, s) 5.0± 1.5 16.3± 7.4∗ 19.6± 7.9∗ 8.9± 4.7 5.3± 1.7 10.5± 4.1
Open-field test
Initial movement (latency, s) 7.2± 1.3 3.3± 1 1.9± 0.6∗ 13.6± 6.7 4.2± 1.7 3.0± 0.9
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(b) Continued.
M non-Tg M TgSED M TgEXE F non-Tg F TgSED F TgEXE
(n = 8) (n = 10) (n = 10) (n = 8) (n = 8) (n = 8)
Open-field test
Exit of the center (latency, s) 14.2± 2.3 10.7± 2 5.2± 1.1∗ 30.4± 13.7 7.6± 2.3 4.4± 1.0∗
Entrance to periphery
(latency, s)
17.0± 5.3 21.7± 8 10.7± 2.5 57.6± 16.9# 10.6± 3.2∗ 7.8± 2.8∗
Vertical activity (latency, s) 49.2± 6.9 75.0± 14 119.7± 31.2∗ 87.5± 17.7 29.5± 5.3#∗ 34.2± 6.4#∗
Self-grooming (latency, s) 173.0± 57.0 172.3± 18 172.1± 18.3 127.8± 11.6 136.9± 23.5 183.0± 21.0
Total self-grooming duration
(s)
3.2± 1.6 3.9± 1.0 6.7± 1.3∗ 4.4± 0.9 5.6± 1.0 3.0± 0.9
Defecation boli (n) 2.0± 0.3 2.7± 0.7 2.8± 0.4 3.2± 0.5 4.4± 0.5 2.9± 0.6
Dark-light box test
Latency to enter into the lit
area (s)
16.2± 2.4 25.5± 5.9 47.4± 28.2 39.4± 12.3 11.5± 2.3∗ 16.1± 5.9
Defecation boli (n) 0.2± 0.2 4.3± 0.7∗ 4.2± 0.5∗ 2.4± 0.4 4.0± 1.3 4.4± 0.7
Morris water maze tasks
Place learning task
Mean speed on day 1 (cm/s) 18.9± 0.8 21.6± 0.9 20.9± 0.7 19.3± 0.8 22.7± 0.7 22.7± 1.2
Mean speed on day 2 (cm/s) 20.6± 0.6 23.4± 1.2 22.7± 0.7 19.4± 1.1 23.8± 0.7 24.0± 1.3
Mean speed on day 3 (cm/s) 22.0± 0.5 21.4± 1.6 23.7± 0.7 19.2± 1.5 23.3± 0.3 23.3± 1.4
Mean speed on day 4 (cm/s) 21.7± 1.2 20.9± 0.8 19.9± 1.1 18.0± 2.0 23.3± 0.7 23.4± 1.3
Mean speed (cm/s) 20.8± 0.7 21.8± 1.0 21.8± 0.6 19.0± 1.1# 23.2± 0.4∗ 23.4± 1.2∗
Probe trial
Annulus crossings (n) 8.0± 1.41 8.4± 1.5 10.1± 1.0 5.6± 0.8 6.3± 1.1 6.9± 0.7
Cue learning task
Mean distance covered (cm) 567.0± 62.5 138.2± 42.4 399.7± 149.9 235.9± 71.0# 312.8± 162.6 293.7± 96.6
Mean speed (cm/s) 19.1± 0.5 19.3± 1.3 20.4± 0.7 14.8±1.6#p 18.8± 1.1p 19.0± 1.4p
T-maze
Performance (latency, s) 8.7± 1.2 12.9± 1.7 11.3± 1.3 20.0± 5.9# 9.9± 1.2∗ 7.8± 1.0∗
Note: non-Tg, nontransgenic mice; TgSED, 3xTgAD mice not exercised; TgEXE, 3xTg-AD mice submitted to a daily treadmill running for five weeks. The
3xTg-AD mice exhibited several behavioral changes indicative of increased neofobia, emotionality, anxiety-like behavior, hyperactivity, and impulsivity,
which were mainly observed in females. The exercise did not induce major changes but showed gender-dependent eﬀects. Results are the mean ± SEM,
n = 8–10 as indicated. Statistics: ∗P < .05 compared to non-Tg; #P < .01 compared to TgSED, pcompared to mean speed on place learning task P < .05.
3. Results
3.1. Physical and Behavioral Profile of 3xTg-AD. Tables 1(a)
and 1(b), Figures 1 and 2(c) summarize the results obtained
in the physical and behavioral assessments of 3xTg-AD mice.
3.1.1. Weight. On a general basis, clear body weight diﬀer-
ences could be observed among the diﬀerent groups with
higher weight recorded in males than females in both non-Tg
and 3xTg-AD mice, while the transgenic genotype involved
a significant increase of weight (see Table 1(a), ANOVA,
F(5,46) = 29.37, P < .001, post hoc Duncan’s test, P <
.05) which was independent of the gender or treatment.
The contribution of WAT to total body weight in the non-
Tg mice was smaller in females (0.3 ± 0.0 g) than in males
(0.8 ± 0.0 g). This gender-dependent eﬀect was completely
lost when genotype was considered, as the weight of WAT
was exactly the same in both genders of 3xTg-AD mice
(M TgSED: 1.0 ± 0.1 g, F TgSED: 1.0 ± 0.0 g, M TgEXE:
1.1±0.2, F TgEXE: 1.0±0.2 g) independent of the treatment.
As illustrated in Figure 2(c), the contribution of WAT to
total body weight (% versus total weight) was similar in all
males independent of genotype or treatment but significantly
higher in both groups of females as compared to the non-Tg
female group [ANOVA, F(5,46) = 5.09, P < .001].
When the weight curve was considered, the repeated-
measures ANOVA indicated a global eﬀect of the “day” factor
(F(24,32) = 7.521, P < .001) which was dependent on gender
(“gender” and “day × gender” interaction eﬀects, F(1,32) =
25.163, P < .001 and F(24,32) = 5.979, P < .001, resp.) with
a 9.3% statistically significant reduction of weight in females
across the test (paired t-test, t = 5.774, df 15, P < .001).
However, there was no influence of the “exercise” factor on
weight (F(24,32) = 0.939, n.s.).
3.1.2. Sensorimotor Tasks. Two-way ANOVA showed gender-
dependent diﬀerences on most of the tasks (gender, all
F’s(1, 35) > 4, 488, P < .05) and a clear beneficial
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Figure 1: Continued.
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Figure 1: All the behavioral tests do consistently refer to presence of BPSD-like symptoms as a characteristic of early stages of the disease
in 3xTg-AD mice, with an important gender component. The eﬀects of exercise are gender dependent. (a) The neophobia in the corner test
was increased in both male and female 3xTg-AD mice. (b and c) The anxious profile could be also observed in several variables measured by
the open-field test and dark-light box. (d) In the Morris water maze, changes in the swim speed and motivation could be recorded and were
mainly important in females (see complementary data in Tables 1(a) and 1(b)). Values are the mean ± SEM, n = 8–10. Statistics: ∗P < .05,
∗∗P < .01, and ∗∗∗P < .001 compared to the corresponding non-Tg; #P < .05, ##P < .01 compared to the corresponding TgSED.
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Figure 2: Peripheral physiological-immunoendocrine function is diﬀerentially impaired in male and female 3xTg-AD mice and is not
ameliorated by treadmill exercise. (a) The IPGT test, indicating plasma glucose levels after an ip injection of glucose, denoted lower tolerance
in female 3xTg-AD (see text for statistics). (b–d) Immunoendocrine function as measured by corticosterone plasma levels (b), white adipose
tissue (WAT) weight (c), and thymus weight (d) was better in females than in males. Values are the mean ± SEM, n = 8–10. Statistics:
∗P < .05 and ∗∗∗P < .001 compared to the corresponding non-Tg; #P < .05, ##P < .01, and ###P < .001 compared to the corresponding
TgSED.
eﬀect of exercise (“exercise,” all F’s(1, 35) > 4, 313) on
the distance covered on both rod tests (coordination),
with “gender x exercise” interaction eﬀects (“gender ×
exercise,” all F’s(1, 35) > 5, 088). The post hoc Duncan’s
test revealed that all females exhibited longer latencies to fall
(equilibrium) than did males when the complexity of the task
was increased (metal rod test) as well as longer latencies to
fall (strength) and more distance covered (coordination and
equilibrium) on the 60 s trial of the hanging test. The benefit
of exercise had a strong gender component, with the group
of treated females showing statistically significant diﬀerences
with respect to the other three groups in terms of the distance
covered on the rod tests (coordination and equilibrium).
3.1.3. Corner Test. As illustrated in Figure 1(a), the normal
behavioral pattern exhibited by NTg mice clearly diﬀered
between genders, with females being more neophobic than
males. On the other hand, two-way ANOVA also showed
gender eﬀects in both horizontal (number of corners) and
vertical activities (number) (all F’s(1, 35) > 6.145, P < .01).
Latency of rearings (see Table 1(a)) was influenced by all fac-
tors (genotype, gender, treatment, and gender × treatment
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interaction eﬀects; all F’s(1, 35) > 4.846, P < .05 and
F(3,34) = 9.752, P < .001, resp.). Exercise did not induce
modifications on the total number of these behaviors
but modified its onset (as mentioned above) and showed
interaction eﬀects with gender in the number and latency of
rearings (all F’s(3, 34) > 6.082, P < .01).
3.1.4. Open-Field Test. Figure 1(b) shows the time course
and total activity developed in the open-field test, while in
Table 1(b), the sequence of behavioral events is indicated.
In the non-Tg mice males and females mainly diﬀered
in the initial horizontal and vertical activities developed in
the test, the latency to reach the peripheral area. Overall, that
also resulted in a total higher activity in males than females
(all P < .05). No diﬀerences in self-grooming or defecation
were recorded.
When the genotype was considered, it was observed that
the behavioral sequence of events was faster developed by
3xTg-AD mice, reaching the statistical significance in most
of the studied variables in the groups with exercise (see
Table 1(b) and Figure 1(b)). Accordingly, the first minute of
the test was the most sensitive to show gender (all F’s(1, 25) >
5.104, P < .05) and genotype diﬀerences, with TgSED
and TgEXE animals being more active than their non-Tg
counterparts (males, all F’s(2, 21) > 5.375, P < .01; females,
all F’s(2, 25) > 3.750, P < .01). Also, the horizontal and
vertical activities developed during the first minute of the
test was diﬀerent between males and females. However, when
the total activity developed during the test was considered,
a genotype × gender interaction eﬀect (all F’s(3, 34) >
3.125, P < .05) was found. Thus, genotype diﬀerences were
maintained in the female groups (TgSED and TgEXE) but
were inversed (vertical activity) in the male groups (TgSED
and TgEXE). Exercise increased self-grooming behavior was
observed in male TgEXE.
3.1.5. Dark-Light Box Test. As in the previous tests (see
Table 1(b) and Figure 1(c)) gender-dependent diﬀerences
between non-Tg males and females were observed and then
disappeared in the 3xTg-AD genotype. TgSED and TgEXE
males exhibited reduced number of entries into the lit area,
and once there they developed less locomotor activity and
increased the number of defecations (all F’s(2, 25) > 3.750,
P < .05). Oppositely, female TgSED and TgEXE increased
their presence in the lit area as it was consistently shown in
all the variables measured in the test (all F’s(2, 21) > 3.508,
P < .05).
3.1.6. Morris Water Maze Tests. Figure 1(d) illustrates the
“day-by-day” and “trial-by-trial” acquisition curves. Results
are expressed in distances because we found gender, geno-
type, and gender × genotype diﬀerences in the swim speed
(see Table 1(b)). In the non-Tg mice, mean speed of females
was slower than males, oppositely of what was found in 3xTg-
AD mice. Besides, mean speed of 3xTg-AD was higher than
that of non-Tg counterparts (F(5,46) = 3.18, P < .05), mainly
in females (see Table 1(b)).
All the animals exhibited a similar acquisition curve (day
eﬀect, F(3,152) = 31.0, P < .001), but in the males the
reduction of the mean distance covered to find the platform
along the four days of the test was faster than in females
(F(5,152) = 2.483, P < .05). Still, no diﬀerences could be
found in the annulus crossing during the probe trial, except
for a general gender eﬀect (F(3,35) = 31, P < .001).
In the cue learning task gender diﬀerences in the non-
Tg groups were also found in the mean distance covered and
the speed, with non-Tg males taking longer and being faster
than non-Tg females (see Table 1(b), t-test, 14 df, P < .05 in
both cases). This gender eﬀect was not observed among the
3xTg-AD groups.
3.1.7. T-Maze. Diﬀerences in the latency to reach the inter-
section of the T-maze were found (F(5,46) = 2.31, P < .05)
with the highest values spent by non-Tg females as compared
with their male non-Tg and female 3xTg-AD counterparts.
No diﬀerences were due to exercise.
3.2. Glucose Tolerance. Results of the IPGTT test are shown
in Figure 2(a). Female 3xTg-AD mice showed decreased
glucose tolerance as related to non-Tg mice. ANOVA showed
an eﬀect for female glucose curves (F(2,84) = 6.764, P <
.005) with the peak of glucose levels (15 min of the IPGTT
test) in female 3xTg-AD mice, both sedentary and exercised
groups, being higher than those measured in non-Tg female
mice (P < .05). On parallel both groups of male 3xTg-AD
mice showed a trend to impaired glucose tolerance albeit it
did not reach statistical significance.
3.3. Immunoendocrine Status. Corticosterone plasma levels
are shown in Figure 2(b). Weight of WAT and thymus are
shown in Figures 2(c) and 2(d). Other weighed organs did
not show any significant diﬀerences between the experimen-
tal groups. There was a “gender” eﬀect on corticosterone
levels (F(1,52) = 1.18, P < .005) and thymus weight (F(1,46)
= 78.02, P < .001). There was a “genotype” eﬀect on thymus
weight (F(2,46) = 20.68, P < .001) and WAT weight (F(2,46)
= 8.051, P < .001), with “genotype × gender” interaction
eﬀects in both weights (F(2,46) = 5.996, P < .005 and F(2,46)
= 5.042, P < .01, resp.). non-Tg females showed higher
corticosterone and thymus weight and lower fat than did
males. 3xTg-AD females showed a decrease in corticosterone
and thymus weight and an increase in fat as compared
to non-Tg females. However, 3xTg-AD females showed a
better immunoendocrine status than did the corresponding
males, as shown by thymus weight. Treadmill exercise had a
minimal eﬀect on these parameters.
3.4. Brain Amyloid Pathology. In order to assess AD pathol-
ogy, we performed Aβ and PHF-tau immunostaining in
sections of male and female 3xTg-AD mice that had been
maintained under sedentary or forced exercise conditions
(Figure 3(a)). Immunoreactivity of 4G8 and AT180 was
evident in hippocampus and amygdala neurons. Treadmill
exercise did not decrease 4G8 and AT180 immunoreactivity
in any of the 3xTg-AD sex groups. Further, we measured
soluble Aβ40 and Aβ42 levels in cerebral cortex of male
and female 3xTg-AD mice (with and without exercise) by
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Table 2: Treadmill exercise recovers the [3H] flunitrazepam binding
parameters of cerebral cortical tissue of 3xTgAD mice.
non-Tg TgSED TgEXE
Males
Bmax (pmol/
mg prot)
1.77 ± 0.32 1.85 ± 0.36 1.58 ± 0.43
Kd (nM) 3.85 ± 0.73 6.46 ± 0.69∗ 3.64 ± 0.69#
Females
Bmax (pmol/
mg prot)
1.21 ± 0.43 1.45 ± 0.65 1.27 ± 0.30
Kd (nM) 3.46 ± 1.61 4.03 ± 2.80 3.20 ± 1.08
Note: non-Tg, nontransgenic mice; TgSED, 3xTgAD mice not exercised;
TgEXE, 3xTg-AD mice submitted to a daily treadmill running for five weeks.
Exercise protected against the decrease of the aﬃnity of [3H] flunitrazepam
for its binding site in the GABA-A receptor, as showed by a low Kd. Results
are the mean ± SEM, n = 3. Statistics: ∗P < .05 compared to non-Tg;
#P < .01 compared to TgSED.
using sandwich ELISA (Figure 3(b)). Both peptides showed
higher levels in females than in males. Two-way ANOVA
analyses showed a significant eﬀect of “gender” on Aβ40
(F(1,9) = 64.97, P < .005) and Aβ42 (F(1,9) = 8.159,
P = .05). Exercise induced an increase in Aβ40 level and a
decrease in the Aβ42/Aβ40 relationship in female mice. Two-
way ANOVA showed a significant eﬀect of “exercise” on the
Aβ42/Aβ40 ratio (F(1,19) = 10.17, P < .05), but no “gender”
eﬀect. We therefore analyzed all animals together using a
two-tailed Student’s t-test, which confirmed that treadmill
exercise decreased the Aβ42/Aβ40 ratio in 3xTg-AD (last
graph in Figure 3(b)).
3.5. GABA Function Alteration. The eﬀects of treadmill
exercise on GABA-A receptor functionality were assayed by
measuring [3H] flunitrazepam binding parameters in male
and female non-Tg mice, 3xTg-AD without exercise and
3xTg-AD with treadmill exercise (Table 2). We observed that
the density of the [3H] flunitrazepam binding sites (Bmax)
was unchanged in both male and female 3xTg-AD compared
to non-Tg.In relation to the dissociation constant (Kd), there
were no binding aﬃnity changes among any of the three
groups of female mice. In contrast, 3xTg-AD males that had
not practiced exercise showed a lower Kd of flunitrazepam
than did non-Tg mice (Kd increased 2.15-fold in 3xTg-AD
versus non-Tg), whereas those subjected to one month of
forced exercise had recovered control aﬃnity levels.
3.6. Oxidative Stress. The eﬀects of exercise on the disturbed
redox homeostasis of 3xTg-AD were studied by analyzing
brain cortex lipid peroxidation levels and the status of
the main antioxidant cell systems. Lipid peroxidation levels
(Figure 4(a)) were increased in 3xTg-AD males as compared
to non-Tg, but this was not the case in females. Exercise
significantly reduced male lipid peroxidation. GSH and
GSSG levels (Figures 4(b) and 4(c)) were significantly
increased in 3xTg-AD males as compared to non-Tg, and
these alterations were not changed by treadmill exercise.
non-Tg females had higher glutathione levels than did
males. Levels were also high in 3xTg-AD females, but
significantly reduced by exercise. GPx activity (Figure 4(d))
was significantly decreased in 3xTg-AD males as compared
to non-Tg, and this was not changed by exercise. non-Tg
females had lower GPx levels than did males. SOD-CuZn
activity (Figure 4(e)) was not changed among the several
groups of male and female mice, but there was increased
SOD-Mn activity (Figure 4(f)) in 3xTg-AD exercised males
compared to non-Tg.
A two-way ANOVA for 3xTg-AD animals indicated an
eﬀect of “gender” in SOD-Mn (F(1,16) = 13.13, P < .005),
GSH (F(1,16) = 90.70, P < .001), GSSG (F(1,18) = 46.80,
P < .001), and GPx (F(1,18) = 23.93, P < .001) as well a
“gender× exercise” interaction with respect to GSH (F(1,16)
= 5.479, P < .05). Accordingly, there was a diﬀerence
between 3xTg-AD sedentary males and females in SOD-Mn
(P < .05), GSH (P < .001), GSSG (P < .001), and GPx
(P < .05), but in exercised male and female 3xTg-AD the
diﬀerence was only observed for GSH (P < .001), GSSG
(P < .001), and GPx (P < .001). In contrast, there were no
diﬀerences between nontransgenic males and females in any
of the redox parameters analyzed. The correlation analysis
showed a direct relationship between SOD-Mn activity and
both GSH and GSSG levels as well as a negative relationship
between SOD-Mn activity and lipid peroxidation levels and
GPx activity.
4. Discussion
In this work we have performed a wide screening in both
genders of 3xTg-AD mice at early stages of the disease and
non-Tg mice. Several levels of study have been considered
from cellular to behavioral ones, including new areas of
interest such as physical condition, glucose homeostasis,
immunoendocrine function, and oxidative stress. The main
interest of the present results has been the description of
diﬀerences of gender, specific for both genotypes, as well as
the beneficial eﬀects that even a short training with forced
exercise can have. Also, the results indicate that interaction
eﬀects between gender, genotype, and treatment should be
always taken into consideration when assessing the outcome
of preventive and/or therapeutic interventions.
The first studies focused on the physical condition.
Expected gender diﬀerences on weight between males and
females were found in both genotypes. The results do also
confirm that the overweight reported from early stages of
the disease in male 3xTg-AD mice of the Spanish colony
[22] is observed in both genders and that females seem to be
more sensitive to some etiological-causal and related factors.
Thus, in this strain background (C57BL/6 x 129S non-Tg
mice) WAT had a statistically significant smaller contribution
to the total body weight in females as compared to males.
However, in the 3xTg-AD mice the total amount of WAT was
equal in both genders, and both the total amount and the
relative contribution of WAT exhibited a three-fold increase
with the triple-transgenic genotype, an eﬀect restricted to
females. Since overweight and glucose metabolism are closely
related, we also studied both basal glycemia and glucose
tolerance. Although the overweight animals did not show
altered basal glucose levels, the increased peak of glucose
observed in both genders of 3xTg-AD confirmed our recent
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Figure 3: Brain pathology in male and female 3xTg-AD sedentary mice (TgEXE) is partially protected against by treadmill running
exercise (TgSED). (a) Representative microphotographs of hippocampus CA1 and basolateral amygdala showing amyloid-β and PHF-
tau immunoreactivity using antibodies 4G8 and AT180, respectively. 4G8 reacts against amino acids 1–17 of amyloid β. AT180 detects
phosphorylated tau at the threonine 321 residue. No changes in intraneuronal amyloid β or PHF-tau were induced by exercise. Scale bar =
20 μm. (b) Levels of soluble amyloid β 40 (Aβ40) and amyloid-β42 (Aβ42) in cerebral cortex as determined by sandwich ELISA. Treadmill
exercise induced a protective change by decreasing the Aβ42/Aβ40 ratio (Aβ42/40) (ANOVA, P = .0110). Values are the mean ± SEM,
n = 3-4. Statistics: ∗P < .05.
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Figure 4: Oxidative stress in the cerebral cortex of sedentary male 3xTg-AD mice (TgSED) is partially ameliorated by treadmill running
exercise (TgEXE), whereas 3xTg-AD females show less alteration. Tissue of sedentary nontransgenic mice (non-Tg) was analyzed as
a reference. (a) Lipid peroxidation levels expressed as malondialdehyde (MDA) plus 4-hydroxyalkenal (4-HAD). (b) Levels of reduced
glutathione (GSH). (c) Levels of oxidized glutathione (GSSG). (d) Glutathione peroxidase (GPx) enzymatic activity. (e) SOD-CuZn
enzymatic activity. (f) SOD-Mn activity. Data represent the mean ± SEM of 4–8 animals, tested in duplicate. Statistics: ∗P < .05, ∗∗P < .01,
and ∗∗∗P < .001 compared to non-Tg; #P < .05 compared to TgSED.
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findings suggesting that glucose homeostasis is compromised
in 3xTgAD mice from early stages of the disease [37]. The
results also suggest that females may be more sensitive than
males (statistical significance was only reached in females). In
addition, other metabolism derangements can be involved in
the increased relative WAT levels in females and the generally
increased body weight in 3xTg-AD mice. For instance,
leptin-related pathways were reported to be impaired with
mice models of AD and leptin treatment ameliorated
cognitive loss [38]. The weight of females was also more
sensitive to repeated handling or exposure to the apparatus
itself, independent of the administration of the treatment,
as a decline in the curve of weight was only observed in
this gender but not in male mice. We cannot assert to
which extent the loss of weight can be related to emotional
reactivity as, on general, blood corticosterone levels did not
diﬀer between both groups of 3xTg-AD females, and, in any
case, the corticosterone levels were lower than that recorded
on non-Tg females. Overall, the results indicate a poorer
ability to maintain weight and glucose homeostasis in female
3xTg-AD mice already at early stages of the disease. The
lack of eﬀects of exercise on weight or glucose tolerance
may be explained by the fact that the profile exhibited by
animals submitted to exercise could be classified as that of
“low runners” and therefore is not enough for such expected
beneficial eﬀects. In fact, the physical condition of both male
and female 3xTg-AD was observed to be lower than that
expected for animals of its age as other strains of mice can
be successfully trained in three diﬀerent treadmill exercise
conditions from minimum (15 min/day, 5 cm·s−1, 0◦ slope)
to moderate exercise (60 min/day, 10 cm·s−1, 0◦ slope) to
exhaustive exercise (60 min/day, 25 cm·s−1, 20◦ slope). Here,
no slope, low initial speed, and a slow increase of speed and
duration of exercise had to be used to avoid animals to get
physically exhausted. Moreover, it was observed that animals
only run when approaching the electric foot-shock panel,
but once reaching the opposite side of the apparatus they
stopped. The pause persisted until arriving to the proximity
of the panel when they felt encouraged again to run to avoid
the negative reinforce. Thus, the 3xTg-AD mice could be
classified as “low or nonrunners” according to the “pause
number” criterion [38].
The behavioral profile which was aimed to assess not
only cognitive but also BPSD-like behaviors which we have
described can be already observed from early stages of the
disease in 3xTg-AD male mice [22, 29]. All the results
obtained in the diﬀerent behavioral tests (corner, OF, and
DLB) consistently indicated gender-dependent diﬀerences
in anxiety-like behaviors in non-Tg mice; that is, non-Tg
females showed increased anxiety as measured by reduced
number of horizontal and vertical activities in the three tests,
increased latencies of some behavioral events in the open
field, and reduced entrance and time spent in the lit area of
the dark-light box as compared to non-Tg males.
The results also showed that the transgenic behavioral
phenotype was characterized by increased BPSD-like behav-
iors. Thus, both male and female 3xTg-AD mice exhibited
a strong increase of neophobia in the corner test which was
nicely observed in the horizontal component (corners), while
the vertical activity levels of 3xTg-AD mice did not diﬀer
from that shown by non-Tg females. The results in the open
field do confirm the increase of anxiety-like behaviors which
imply a faster sequence of events related to thigmotaxis
or preference for protected areas in the test (leaving the
central square to enter in the peripheral ring) and increased
horizontal activity (hyperactivity in females). In contrast,
the vertical activity in the three groups of both males and
females found a strong parallelism with that exhibited in
the corner tests and that to be observed in the dark-light
box on the next day. In the DLB, the BPSD-like behaviors
exhibited by both groups of 3xTg-AD mice were gender
dependent. Disinhibitory behavior was observed in TgSED
and TgEXE females as compared to non-Tg females. The
BPSD-like behavior in males was manifested as increased
anxiety (reduction in the number of entries and therefore
of horizontal and vertical activities, increased defecatory
behavior) although in previous works we have also been able
to observe the disinhibitory eﬀect in males [22].
When the animals were tested for spatial learning and
memory in the diﬀerent paradigms of MWM, no diﬀerences
could be found on their learning and memory abilities. How-
ever, the main finding was an increased speed during all the
days of the tests in the female groups (TgSED and TgEXE),
although in current investigations we have found this eﬀect
also in 3xTg-AD males. The speed was reduced in the cue
learning task albeit only reached statistical significance in
non-Tg mice and 3xTgAD females (TgSED and TgEXE),
but it is indicative of genotype and genotype-dependent
diﬀerences in motivation or emotionality, in agreement with
the increase of BPSD-like behaviors observed in the other
tests. Genotype-dependent diﬀerences in thermoregulation
[22] could also account for the observed diﬀerences in
swimming speed. These results are also aware about the
relevance of analysing the trajectories on parallel to the
traditional latency measurement.
In a previous study [24] we have described gender-
dependent neuroimmunoendocrine disfunction in 3xTg-
AD at advanced stages of the disease (15 month of age).
In this work, the weight of thymus was used as an
indirect indicator of immunological functional state, with
involution of thymus showing a correlation with diﬀerences
in immunological function [39] and immunological aging
[40]. As expected, the total weight of thymus was higher
in females than in males, and this gender diﬀerence was
more obvious when its relative weight was considered,
suggesting a better immune function in the female gender.
Interestingly, although this gender-dependent protection was
still persistent in 3xTg-AD females, it was strongly reduced
as compared to the one exhibited by non-Tg females. Also in
males, the transgenic phenotype resulted in involution of the
weight of thymus albeit it only reached statistical significance
in one of the transgenic groups. Therefore, the present results
show an involution of thymus in adult 3xTg-AD mice and
suggest that the gender-dependent neuroimmunoendocrine
disfunction described in old 3xTg-AD mice [24] may find a
clear correlation with impaired immunological function at
early stages of the disease, a subject which is under current
investigations. Related to this, female 3xTg-AD mice were
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very fast to reach the intersection of the T-maze as compared
to the non-Tg females. This fast performance could be more
fight counterpart to the flight copying with stress strategy
(slow performance) than has been related to premature
accelerated neuroimmunoendocrine system in mice [32].
When considering neuropathological aspects, it is known
that at six month of age, 3xTg-AD mice develop intra-
neuronal Aβ as a characteristic pathological feature of this
AD mouse model [20, 21]. Aβ deposits appeared slightly
larger in females than in males, in agreement with previous
observations in this mouse [41]. These mice showed intra-
neuronal PHF-tau. At this early age the phosphorylation at
Thr321 in intraneuronal tau can be added to that previously
described for Thr212, Ser214, and Ser262 in soluble tau
[42]. The exercise paradigm used (forced treadmill running)
did not ameliorate Aβ deposits or PHF-tau pathology.
Other authors also reported no plaque reduction with a
similarly short exercise treatment in a freely available wheel
[43, 44]. Brain levels of soluble Aβ40 and Aβ42 at 7
months of age were low in comparison to levels of more
than 100 fmol/mg reported at 13 months [20]. Interestingly,
the two-way ANOVA showed that Aβ levels were, overall,
higher in females than in males. Therefore, this increased
level may cause the greater behavioral alterations observed
in young adult females compared with males (this study,
[41]).
In the neurochemical approach, we considered under-
lying mechanisms of BSPD-like symptoms that model
noncognitive AD deterioration which are yet needed to be
further explored in these mice. The GABAergic system is
considered to be involved in depressive symptoms in AD
[45], and the lowered aﬃnity for flunitrazepam binding
found in 3xTg-AD males paralleled that reported in the
temporal cortex of AD patients [45]. The GABAergic system
is less sensitive to the neurodegeneration process than are
other neurotransmitter receptors, and GABA-A receptors are
relatively well preserved in AD. However, particular receptor
subunits may be altered, leading to compensatory changes
or physiological disturbances [46, 47]. Forced exercise
reversed the flunitrazepam binding aﬃnity to non-Tg values,
although it barely ameliorated the anxiety and depression-
like behaviors, as discussed above. Therefore, there is gender
dualism in the mechanisms underlying noncognitive behav-
iors in these AD mice, and BPSD are probably derived from
disturbances in several neurotransmitter systems and the
subsequent imbalance that is caused [45, 48].
Finally, although conclusive evidence is still lacking, the
oxidative stress hypothesis of AD may help to explain the
triggering of AD neurodegeneration by environmental or
genetic factors [49]. Indeed, AD brain shows an elevation of
markers for oxidative damage [50–53], and the prevalence
of these markers is higher in initial than later stages of
the disease, suggesting an involvement of oxidative stress
in AD etiology [54, 55]. Therefore, treatments that help
to restore redox homeostasis may delay or ameliorate AD
pathology. The presence of brain oxidative stress in 3xTg-
AD mice at an early age of 3–5 months (females) has been
previously reported [56]. In this study, older mice aged
7 months showed fewer changes in oxidative stress. The
main eﬀect found was an increased lipid peroxidation and a
derangement of the glutathione system in males. The latter
disturbance is consistent with the glutathione metabolism
gender alteration in AD male patients [57]. One of the
mechanisms involved in physical exercise is the regulation of
redox homeostasis. Chronic nonstrenuous exercise decreases
oxidative damage and increases antioxidant defenses in brain
[4]. Accordingly, 3xTg-AD male rats submitted to treadmill
exercise showed a decreased level of lipid peroxidation.
Exercise also increased the activity level of SOD-Mn, the first
line of defense against mitochondrial oxidative damage. No
amelioration of the glutathione system changes was obtained
in males, but a decreased oxidization of glutathione was
observed in females.
5. Conclusions
Physical exercise is a promising intervention against AD,
and the use of a good model such as the 3xTg-AD
mice will enable the best exercise strategies to be defined.
Five weeks of forced treadmill exercise partially protected
3xTg-AD mice against AD-like pathology. However, the
results diﬀered according to gender, this being due to the
diﬀerential pathological phenotype of 3xTg-AD males and
females, in agreement with previous reports [19, 20, 58].
Specifically, we found that males showed more homeostasis
redox derangement than did females, while females showed
greater brain AD pathology compared with males. Peripheral
immunoendocrine status was better in females than in males,
even though 3xTg-AD females were impaired with respect
to non-Tg females. Therefore, the 3xTg-AD mouse models
human gender diﬀerences in the progression and expression
of the disease. The results of this study corroborate the
beneficial eﬀects of a short burst of physical exercise at
a moderate stage of AD neurodegeneration (7 months of
age), even though these eﬀects were rather modest. Studies
with voluntary exercise are ongoing [41], as this might
induce greater neuroprotective eﬀects than does forced
exercise [59]. We speculate that over a short training
period the stress associated with the mandatory treadmill
exercise may partially interfere with the beneficial aerobic
eﬀects.
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